Concepedia

Publication | Open Access

Trametinib Activity in Patients with Solid Tumors and Lymphomas Harboring BRAF Non-V600 Mutations or Fusions: Results from NCI-MATCH (EAY131)

DOIFull Paper Access

88

Citations

30

References

2020

Year

Douglas B. Johnson, Fengmin Zhao, Marcus Smith Noel, Gregory J. Riely, Edith P. Mitchell, James R. Wright, Helen X. Chen, Robert J. Gray, Shuli Li, Lisa M. McShane,
Clinical Cancer Research

Abstract

Trametinib did not show promising clinical activity in patients with tumors harboring non-V600 <i>BRAF</i> mutations, and the subprotocol did not meet its primary endpoint.

References

YearCitations

Page 1